Clozapine and haloperidol modulate N-methyl-D-aspartate- and non-N- methyl-D-aspartate receptor-mediated neurotransmission in rat prefrontal cortical neurons In Vitro

The effects of the antipsychotic drugs haloperidol and clozapine on N- methyl-D-aspartate (NMDA) and non-NMDA receptor-mediated neurotransmission were examined and compared in pyramidal cells of the medial prefrontal cortex in rat brain slices by using the techniques of intracellular recording and single-electrode voltage-clamp. The bath administration of either haloperidol or clozapine produced a marked facilitation (300400%) of NMDA-evoked responses in a concentration-dependent manner. The EC₅₀ values of haloperidol and clozapine were 38 and 14 nM, respectively. At concentrations of ≤100 nM, clozapine, but not haloperidol, produced bursts of excitatory postsynaptic potentials (EPSPs), which were blocked by glutamate receptor antagonists, suggesting that these EPSPs were the result, of increasing release of excitatory amino acids. Haloperidol, but not clozapine, produced a concentration-dependent inhibition of α-amino-3-hydroxy-5-methyl-4- isoxazolepropionic acid-induced current with an EC₅₀ value of 37 nM. Haloperidol significantly decreased the amplitude of EPSPs evoked by the electrical stimulation of the forceps minor, whereas clozapine increased the amplitude of these EPSPs. The study of current-voltage relationship indicates that clozapine preferentially potentiates NMDA receptor-mediated transmission, whereas haloperidol depresses the non-NMDA receptor-mediated response which probably obscures its potentiating effect on NMDA receptor- mediated EPSPs.